SGC Open Notebook Project to Characterize the HMTase NSD3 Exp018 Objective:To generate cell lines stably expressing NSD3-Short-3xFLAG in relevant cell backgrounds. These cell lines can be used to assay phenotypes associated with over-expression and to study NSD3-short protein-protein / protein-chromatin interactions. The lentiviral vectors used here have been modified by replacing an IRES bicistronic element with a T2A self-cleaving peptide sequence (cloning described in exp-016) for expression of NSD3short-3xFLAG and a puromycin selection marker.

Funding Acknowledgment: The SGC is a registered charity (number 1097737) that receives funds from AbbVie, Bayer Pharma AG, Boehringer Ingelheim, Canada Foundation for Innovation, Eshelman Institute for Innovation, Genome Canada through Ontario Genomics Institute [OGI-055], Innovative Medicines Initiative (EU/EFPIA) [ULTRA-DD grant no. 115766], Janssen, Merck KGaA, Darmstadt, Germany, MSD, Novartis Pharma AG, Ontario Ministry of Research, Innovation and Science (MRIS), Pfizer, São Paulo Research Foundation-FAPESP, Takeda, and Wellcome.